Barrington lowered the firm’s price target on Cimpress (CMPR) to $95 from $119 and keeps an Outperform rating on the shares following the fiscal Q2 report. Management believes the disappointing results were due to short-term factors, and the company remains confident in its favorable long-term outlook, the analyst tells investors in a research note.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMPR: